Measles remains one of the most important causes of childhood death despite the availability of a safe and effective vaccine [1] . Infection is associated with immune activation, as well as immune suppression and increased susceptibility to other infections [2, 3] . Measles is usually diagnosed with the onset of fever and rash, manifestations of the cellular adaptive immune response that occur 10-14 days after infection and mark the initiation of virus clearance. Previous studies of the immune response to measles virus (MeV) infection during the rash have indicated that the innate response is characterized by production of interleukin 1β, 6, and 18 (IL-1β, IL-6, and IL-18) without production of type I interferon (IFN) or interleukin 12 and that the early adaptive CD4 + and CD8 + T-cell response is characterized by production of IFN-γ and interleukin 2 (IL-2) [2, [4] [5] [6] [7] [8] [9] . Type 2 cytokines are produced later in the recovery phase of measles, coincident with the evolving antibody response [4, 8] . Expression of chemokines, which are important for cell homing to infected tissues, have not been previously studied and there is no information on how production of these soluble immune factors relate to outcome or are affected by coinfection with human immunodeficiency virus type 1 (HIV-1).
Known risk factors for measles-associated death include malnutrition, young age, vitamin A deficiency, HIV coinfection, lack of prior measles vaccination, and lack of access to medical care [10] [11] [12] . Immune response predictors of death have not been evaluated but are of interest, considering the profound effects that MeV infection has on the immune system and the need to balance clearance mechanisms and potential immunopathological effects. In some viral infections, high levels of proinflammatory cytokines and chemokines are associated with severe or fatal disease. For instance, levels of IL-6, interleukin 10 (IL-10), CCL2, CCL4, and CXCL8 are more elevated in severe cases of Ebola virus disease and severe fever with thrombocytopenia syndrome [13, 14] .
In influenza virus infection, levels of IL-6, CCL2, CXCL8, and CXCL10 predict severe H7N9 disease; levels of tumor necrosis factor (TNF) α, IL-6, interleukin 15, and CXCL8 are correlated with severity, and levels of IL-6 predict admission to the intensive care unit for pandemic H1N1 influenza [15] [16] [17] [18] . In these infections it is postulated that excessive cytokine production is both locally damaging to tissue and produces sepsislike systemic responses leading to poor outcome. A role for "cytokine storm" in acute measles-associated death has not been recognized to our knowledge. To identify more broadly the immune factors produced during the acute phase of measles and determine whether cytokine or chemokine levels predict death or are altered in the presence of HIV coinfection, we measured levels of 22 cytokines and chemokines in plasma collected from children hospitalized with measles in Lusaka, Zambia.
MATERIALS AND METHODS

Study Subjects
Samples were selected for study from frozen and archived plasma samples collected in Lusaka, Zambia, from 1999 to 2003 [11, 19] ; 148 samples were from children admitted to the University Teaching Hospital with measles and collected within 1-2 days after admission (median age [interquartile range], 13.5 [7.75-34.25] months; median time after rash onset, 4 [3-5] days). As described elsewhere, a diagnosis of measles was confirmed by detection of MeV-specific immunoglobulin M antibody (Wampole Laboratories; sensitivity, 93.3%; specificity, 97.4%), and HIV-1 coinfection was determined by means of reverse-transcription polymerase chain reaction [19] .
Samples chosen for analysis were selected from the original population of 1227 children with confirmed measles who had been tested for HIV-1 infection (189 positive samples). Of the samples analyzed, 66 were from children coinfected with HIV-1, and 82 from children without HIV infection. Eighteen of the HIV-infected and 35 of the HIV-uninfected children died in the hospital (Table 1) and represented approximately 80% of the children in the cohort who died. Plasma from approximately 50 HIV-uninfected and 50 HIV-infected children who survived, balanced by sex, were chosen for comparison. Forty-four samples collected from healthy children seeking routine measles vaccination from 2000 to 2002, of whom 20 were infected with HIV-1, were used as controls (median age, 9.07 months; interquartile range, 9.01-9.36 months).
Cytokine and Chemokine Assays
Multiplex T-helper (Th) 1/Th2 cytokine and chemokine electrochemiluminescence assays from Meso Scale Discovery (MSD)  were used according to the manufacturer's instructions for  measurement of TNF-α, IL-1β, IL-2, interleukin 4, 5, 10, 12p70,  and 13 (IL-4, IL-5, IL-10, IL-12p70, and IL-13) , IFN-γ, CCL2/ macrophage chemotactic protein (MCP) 1, CCL4/macrophage inflammatory protein 1β, CCL11/eotaxin, CCL13/MCP-4, CCL17/thymus and activation regulated chemokine, CCL22/ macrophage-derived chemokine, CCL26/eotaxin3, CXCL8/ interleukin 8, and CXCL10/ IFN-γ-inducible protein 10. Data were acquired using the SECTOR2400 instrument. The MSD method has a large dynamic range, has been extensively evaluated, and is comparable or superior to other methods for measurement of cytokine levels in human serum samples [20] . IL-6, interleukin 17 (IL-17), IL-18, and CCL5/RANTES (regulated on activation of normal T cells expressed and secreted) were measured using enzyme immunoassay according to the manufacturer's instructions (eBiosciences; R&D Systems). All samples were assayed in duplicate, and serially diluted standards were included in each assay. Owing to limited sample availability, not all assays could be performed in all children.
Data Analysis
For MSD plates, the standard curves for each plate were manually examined and adjusted based on a coefficient of variation (<15%) and percentage recovery (80%-120%). Detection limits differed slightly among analytes, with a range of 0.09-2500 pg/ mL for cytokines and 0.5-5000 pg/mL for chemokines. Limits of detection for each are provided in Supplemental Table S1 . For the purposes of analysis, plasma samples with undetectable cytokine levels were assigned a value of 1 pg/mL (IL-6, IL-17, and CCL17) or 0.03 pg/mL (IL-2 and IL-13). Heat map clustering was done using Partek Genomics Suite v6.0 software (Partek). Data were first normalized to the mean value of each mediator in the plasma of healthy control children and then transformed on a log 2 scale. Euclidean distance between immune mediators was calculated and grouped by centroids linkage analysis. Individual groups were compared using the Mann-Whitney U test, and multiple groups were compared using Kruskal-Wallis rank sum analysis with Dunn correction for multiple comparisons. Differences were considered significant at P < .05. Statistical analyses were performed using Stata Release 10 statistical software (StataCorp).
Ethics Statement
The study protocol was approved by the institutional review boards of the Johns Hopkins Bloomberg School of Public Health and the University of Zambia. Written informed consent was obtained from a parent or guardian for all children enrolled in the study.
RESULTS
Clinical Characteristics of Study Children
Children acquiring measles in Zambia during the study period were mostly <5 years old with a risk for in-hospital death of 4.3% for HIV-uninfected and 12.2% for HIV-infected children [11, 19] . Archived plasma samples from 148 children were chosen from this population for study of plasma cytokine and chemokine levels. These samples included most of those available from children who died and approximately 50 HIV-infected and 50 HIV-uninfected children who survived. Children in each group had a similar duration of rash at the time of hospitalization (Table 1) . Most children had no history of prior measles vaccination, and the groups did not differ by sex, maternal education, presenting signs and symptoms, vitamin A or antibiotic administration. We first determined the patterns of cytokine and chemokine production associated with MeV infection compared with controls in HIV-uninfected children and then compared levels between children with measles who survived and those who died in the hospital. Finally, we determined the effect of HIV infection on cytokine and chemokine production.
Effect of MeV Infection
To determine the effect of MeV infection on plasma cytokine and chemokine levels during the acute rash phase of the disease, we compared HIV-uninfected children hospitalized with measles with HIV-uninfected healthy control children (Figures 1 and 2 ). Plasma levels of innate cytokines TNF-α, IL-1β, IL-18, and IL-6 were increased during measles while levels of IL-12p70 were not. Plasma levels of MCP CC chemokines CCL2 and CCL13, macrophage inflammatory protein CC chemokine CCL4, CCL11 and CCL22, and CXC chemokines CXCL8 and CXCL10, were higher in children with measles than in control children, whereas CCL5, CCL17 and CCL26 levels were not significantly increased (Figure 1 ). Plasma levels of T-cell cytokines IFN-γ, IL-2, IL-10, and IL-17 were also higher in children with measles than in controls, and levels of IL-4, IL-5, and IL-13 were not ( Figure 2 ). No differences in cytokine or chemokine levels were identified between boys and girls (Supplemental Table S2 ). These data are consistent with nuclear factor κB (NF-κB) and inflammasome activation during the innate response and activation of Th1/cytotoxic T cell (Tc) 1, Th17/Tc17, and regulatory T cells, but not Th2/Tc2 cells in the adaptive immune response approximately 4 days after rash onset.
Association With In-Hospital Mortality
The median age of HIV-uninfected children who died (11.3 months) did not significantly differ from the median age of those who survived to discharge (15.7 months) (P = .29), with pneumonia (97%) and diarrhea (69%) as common complications (Tables 1 and 2 ). To determine whether levels of cytokines and chemokines differed between those who survived and those who died in the hospital, these groups were compared ( Figures 3 and 4) . Heat map analysis indicated separate clustering of cytokine and chemokine levels for control children, children with measles who survived to discharge, and children with measles who died in the hospital, with generally higher cytokine and chemokine levels for children who died than for children who survived ( Figure 3 ). To identify specific cytokines and chemokines that distinguished the groups, levels of individual factors were compared ( Figure 4 ). Levels of innate cytokines TNF-α and IL-1β, elevated in children with measles compared with controls (Figure 1 ), were higher in those who died. Levels of IL-12p70, which were not significantly higher in children with measles than in controls (Figure 1 ), were also higher in those who died than in those who survived to discharge (Figure 4) . Levels of IL-18 did not differ (Table 3) .
Levels of inflammatory chemokines CCL2, CCL4, CCL13, CXCL8, and CXCL10, all elevated in children with measles compared with controls (Figure 1 ), were more elevated in children who died in the hospital than in those who survived to discharge (Figure 4 ) whereas levels of CCL11 and CCL22, also increased in children with measles, did not differ between the outcome groups (Table 3) . CCL17 levels, which were not significantly increased in measles (Figure 1 ), were also higher in those who died (Figure 4) .
Adaptive type 1 T-cell cytokines IL-2 and IFN-γ, elevated in children with measles compared with controls ( Figure 2 ), were higher in those who died (Figure 4) . Interestingly, IL-4, a type 2 cytokine that did not differ between children with measles and controls (Figure 2 ), had lower levels in those who died than in those who survived to discharge (Figure 4) , whereas the other type 2 cytokines examined, IL-5 and IL-13, as well as IL-10 and IL-17, did not show differences (Table 3) . Together, these data are indicative of more intense inflammatory responses with an increase in type 1 but not type 2 T-cell cytokines in children with more severe disease.
Effect of HIV-1 Infection
To determine the effect of infection with HIV-1 on cytokine and chemokine levels, children without HIV infection were compared with those with HIV infection in the control groups and in the MeV-infected groups of children who survived and who died (Table 3) . HIV-infected control children without measles had higher plasma levels of TNF-α, IL-1β, CCL5, CCL11, CCL13, CCL22, CCL26, IL-2, and IL-13 than HIV-uninfected control children. HIV-infected children with measles who survived had higher levels of TNF-α and IL-1β and lower levels of IL-4 and IL-5 than HIVuninfected children with measles who survived. There were no significant differences in the cytokine or chemokine levels between HIV-infected and HIV-uninfected children who died. Comparisons of levels in HIV-infected male and female children showed significant differences only for chemokines CCL4 (higher in surviving girls) and CCL11 (higher in nonsurviving boys) (Supplemental Table S2 ). These data are indicative of baseline immune activation with HIV infection in young children and, in response to MeV infection, further activation of macrophages and a skewing of T-cell responses toward production of type 1 cytokines and suppression of type 2 cytokines. 
DISCUSSION
Increases of immune mediators in circulation are part of the response to viral infection and provide information on the types and intensity of responses elicited by infection. In these studies, we have shown that the acute rash phase of measles is associated with elevated plasma levels of innate inflammatory cytokines TNF-α, IL-1β, IL-6, and IL-18; inflammatory CC and CXC chemokines CCL2, CCL4, CCL11, CCL13, CCL22, CXCL8, and CXCL10; and T-cell cytokines IL-2, IFN-γ, IL-10, and IL-17. This pattern is consistent with innate responses linked to monocyte/ macrophage activation of the nucleotide-binding oligomerization domain (NOD)-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome and NF-κB pathways, infected tissue production of lymphocyte and monocyte-attracting chemokines, and induction of type 1, type 17, and regulatory T lymphocytes. Of these, inflammatory cytokines TNF-α, IL-1β, and IL-6; chemokines CCL2, CCL4, CCL13, CXCL8, and CXCL10; and T-cell cytokines IL-2 and IL-17, plus IL-12p70 and CCL17, were more elevated in children who died in the hospital than in those who survived to discharge. These data suggest a potential role for heightened innate and type 1 immune activation in acute measles mortality, in contrast to the state of immune suppression postulated to be responsible for delayed measles mortality from secondary infections. Finally, coinfection with HIV-1 was associated with higher levels of innate cytokines TNF-α and IL-1β and lower levels of type 2 cytokines IL-4 and IL-5 than in children with measles not coinfected with HIV-1, suggesting augmented activation of innate responses and a suppression of type 2 responses during measles in HIV-infected children.
TNF-α, IL-1β, and IL-6 are endogenous pyrogens that mediate the induction of fever characteristic of the rash phase of measles (Table 1) [21] [22] [23] . These innate cytokines can be produced by activated or infected cells in many tissues but are most commonly produced by activated monocyte/macrophages. MeV infects multiple types of cells, including lymphocytes, monocyte/macrophages, epithelial cells, and endothelial cells [24] that probably vary in their response to infection and cytokine production. For instance, MeV-infected A549 epithelial cells show little cytokine production [25] , whereas infection of myeloid cells stimulates assembly of the NLRP3 inflammasome with activation of caspase-1, followed by cleavage and secretion of mature IL-1β and IL-18 [26, 27] . However, cellular production of IL-1β and IL-18 requires prior priming through Toll-like receptor (TLR)-or TNF-α-induced NF-κB signaling to induce synthesis of pro-IL-1β and the inflammasome nucleotide-binding oligomerization domain (NOD)-like receptor NLRP3, which are otherwise present at low levels [28, 29] .
In addition to interaction of viral RNA with TLR3 and TLR7, the wild-type MeV hemagglutinin receptor attachment glycoprotein interacts with TLR2 to activate NF-κB signaling [30] . Previous studies have shown that expression of the messenger RNAs for IL-1β and NLRP3 are increased in peripheral blood mononuclear cells (PBMCs) during measles [6] . Once produced, IL-1β further amplifies IL-1β production in an autocrine feedback loop [29] . Because deaths associated with measles are usually due to secondary infections, particularly bacterial pneumonia, and inflammasome activation in response to bacterial infection in mice contributes to a sepsislike syndrome Abbreviation: HIV, human immunodeficiency virus.
a Discrepancies in denominators are due to missing data for some children.
and death [31] , this pathway may also be contributing to measles-associated death. TNF-α is rapidly produced by many types of cells including lymphocytes, monocyte/macrophages, dendritic cells, and fibroblasts in response to cytokine, pathogen, or antigen stimulation [32] . Interaction of TNF-α with its receptor activates NF-κB signaling and can further increase inflammation by inducing cell necrosis [32, 33] . Increased plasma levels of TNF-α in measles are consistent with increased levels of tnfa messenger RNA in PBMCs and spontaneous production of TNF-α protein by PBMCs cultured from children with measles [6, 34] .
IL-6 is promptly produced by macrophages, as well as other cells, in response to NF-κB signaling stimulated by IL-1β, TNF-α, or TLR engagement [29, 30] . IL-6 participates in the induction of an inflammatory cascade by trans-signaling through its soluble receptor for engagement of ubiquitously expressed gp130 and a Jak/STAT3 signaling pathway to stimulate synthesis of acute phase proteins by hepatocytes, promote B-cell differentiation, and direct leukocyte trafficking [35, 36] . IL-6 is increased in malnourished children with measles [9] , plays a major role in a variety of potentially fatal systemic inflammatory response syndromes characterized by fever and increased vascular permeability, and has been linked to adverse outcome in infections with HIV, influenza, dengue, and severe fever with thrombocytopenia syndrome viruses [13, 15-18, 37, 38] Its effects can potentially be modulated by treatment with an IL-6 receptor-blocking antibody [39] . TNF-α, IL-1β, and IL-6 stimulation of NF-κB and STAT signaling leads to production of a broad range of inflammatory chemokines with activated macrophages as a major source. IL-6 amplifies the production of inflammatory factors by stimulating production of CCL2 and CXCL8, as well as more IL-6. CCL2 is important for recruitment of Ly6C + inflammatory monocytes expressing CCR2 into infected tissues [40] , promotes vascular adhesion, and is frequently elevated in virus-induced immune activation [13, 18, 41] .
Other cells can also be important sources of chemokines. For instance, T cells produce CCL4 and CCL11 [42] , and epithelial cells can be a source of CCL13 and CXCL8 [43] . CXCL8 is a chemoattractant for neutrophils and T cells and has been associated with severe disease due to respiratory syncytial virus infection in infants [44] . Skin-specific chemokines CCL17 and CCL22 are produced by keratinocytes [45] and attract inflammatory cells, particularly CCR4-expressing type 2 and regulatory T cells, to skin and may play a role in the measles rash.
Innate cytokines also provide stimuli important for induction of the adaptive immune response [46] . Although measles immune suppression is known to have profound impact on immune responses to other infections, our data show that mortality after measles was probably not due to insufficient immune activation; rather, we found that children who died had higher levels of innate and T-cell cytokines. It is possible that the burden of secondary bacterial infection and the genetic variation regulating innate activation in the host could contribute to measles mortality. Future animal studies using blocking antibodies to different cytokines, particularly those in the inflammasome pathways, could provide more mechanistic insights. The T-cell cytokines elevated in children with measles in this study are consistent with the previously observed preferential early activation of Th1/Tc1 (IFN-γ, IL-2, and CCL4), Th17/Tc17 (IL-17), and regulatory T (IL-10) cells [4, 8] . IFN-γ induces expression of CXCL10, an important chemotactic factor for migration of CXCR3-expressing B and T lymphocytes into infected tissues [47] . Both IFN-γ and CXCL10 are elevated in measles, with highest levels in children who died. CXCL10 is also an indicator of severity in other viral infections and is associated with failure of hepatitis C virus clearance [48, 49] .
Development of more severe or fatal viral disease has been associated with elevated plasma levels of cytokines (cytokine storm) during H1N1 and H7N9 influenza [15] [16] [17] [18] , severe fever with thrombocytopenia [13] , Ebola virus disease [14] and enterovirus 71 encephalitis [50] . In these infections, increases that correlate with disease severity most often include IL-6 and CXCL8, followed by IL-1β, CCL2, CCL4, and CXCL10, factors also elevated to similar levels in measles with poor outcome. These factors are primarily associated with the innate immune response, rather than the T-cell response; are produced in response to virus infection of target cells, such as monocytes, tissue macrophages, epithelial cells, and endothelial cells; and may be associated with higher virus load [13, 14] .
The early innate immune response and the resulting antiviral state may influence viral load and systemic spread, leading to differences in the production of cytokines and chemokines, as well as outcome, but we were unable to evaluate this possibility because PBMCs from these children were not available for analysis of viral load. Other limitations of this study include an inability to evaluate production of innate cytokines earlier in infection and the small sample size for HIV-infected children who died in the hospital. Successful treatment of immunologically mediated disease related to excessive cytokine production [39] suggests that similar interventions might be useful in severe acute measles.
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